Literature DB >> 12892129

Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov.

Tom Coenye1, Johan Goris2, Paul De Vos2, Peter Vandamme2, John J LiPuma1.   

Abstract

Thirteen Ralstonia pickettii-like isolates from the environment (water, soil and activated sludge) and human clinical samples (including respiratory secretions of cystic fibrosis patients) were investigated in a polyphasic taxonomic study that employed 16S rDNA sequence analysis, DNA-DNA hybridization, determination of DNA base composition, whole-cell protein analysis, biochemical characterization and PCR-based assays. All isolates were classified as a novel Ralstonia species, for which the name Ralstonia insidiosa sp. nov. is proposed. The type strain, LMG 21421T (= CCUG 46789T), was isolated from the sputum of a patient with acute lymphoblastic leukaemia. R. insidiosa can be differentiated from other species of the genus Ralstonia and phenotypically similar species (including the Burkholderia cepacia complex and Achromobacter xylosoxidans) by a variety of biochemical tests, whole-cell protein analysis and several PCR-based assays. Some outstanding issues in the taxonomy of the genus Ralstonia are also discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892129     DOI: 10.1099/ijs.0.02555-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  32 in total

1.  Incidence, relevance and response for Ralsfonia respiratory infections.

Authors:  Jonathan B Waugh; Wesley M Granger; Amit Gaggar
Journal:  Clin Lab Sci       Date:  2010

2.  An assessment of microbial communities associated with surface mining-disturbed overburden.

Authors:  Dominique M Poncelet; Nicole Cavender; Teresa J Cutright; John M Senko
Journal:  Environ Monit Assess       Date:  2013-11-06       Impact factor: 2.513

3.  Differentiating the growing nosocomial infectious threats Ralstonia pickettii and Ralstonia insidiosa.

Authors:  M P Ryan; J T Pembroke; C C Adley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-02       Impact factor: 3.267

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Specific PCR to identify the heavy-metal-resistant bacterium Cupriavidus metallidurans.

Authors:  Michael P Ryan; Catherine C Adley
Journal:  J Ind Microbiol Biotechnol       Date:  2011-07-01       Impact factor: 3.346

6.  Combination of 16S rRNA variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients.

Authors:  Melissa S Doud; Michael Light; Gisela Gonzalez; Giri Narasimhan; Kalai Mathee
Journal:  Hum Genomics       Date:  2010-02       Impact factor: 4.639

7.  Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis.

Authors:  Tom Coenye; Theodore Spilker; Rebecca Reik; Peter Vandamme; John J Lipuma
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

8.  Cupriavidus and Burkholderia species associated with agricultural plants that grow in alkaline soils.

Authors:  Paulina Estrada-de Los Santos; Nora Belinda Vacaseydel-Aceves; Lourdes Martínez-Aguilar; María Antonia Cruz-Hernández; Alberto Mendoza-Herrera; Jesús Caballero-Mellado
Journal:  J Microbiol       Date:  2011-12-28       Impact factor: 3.422

9.  Airway infection with a novel Cupriavidus species in persons with cystic fibrosis.

Authors:  Wiltrud Maria Kalka-Moll; John J LiPuma; Frank J Accurso; Georg Plum; Silke van Koningsbruggen; Peter Vandamme
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

10.  First investigation of the microbiology of the deepest layer of ocean crust.

Authors:  Olivia U Mason; Tatsunori Nakagawa; Martin Rosner; Joy D Van Nostrand; Jizhong Zhou; Akihiko Maruyama; Martin R Fisk; Stephen J Giovannoni
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.